Scientific article
OA Policy
English

Management of bleeding and emergency invasive procedures in patients on dabigatran: Updated guidelines from the French Working Group on Perioperative Haemostasis (GIHP) - September 2016

Published inAnaesthesia Critical Care & Pain Medicine, vol. 37, no. 4, p. 391-399
Publication date2018
Abstract

In 2013, the GIHP published guidelines for the management of severe haemorrhages and emergency surgery. This update applies to patients treated with dabigatran, with a bleeding complication or undergoing an urgent invasive procedure. It includes how to handle the available specific antidote (idarucizumab), when to measure dabigatran plasmatic concentration and when to use non-specific measures in these situations. It also includes guidelines on how to perform regional anaesthesia and analgesia procedures.

Keywords
  • Dabigatran
  • Emergency
  • Dabigatran concentration
  • Antidote
  • Bleeding
  • Surgery
Citation (ISO format)
ALBALADEJO, Pierre et al. Management of bleeding and emergency invasive procedures in patients on dabigatran: Updated guidelines from the French Working Group on Perioperative Haemostasis (GIHP) - September 2016. In: Anaesthesia Critical Care & Pain Medicine, 2018, vol. 37, n° 4, p. 391–399. doi: 10.1016/j.accpm.2018.04.009
Main files (1)
Article (Published version)
Identifiers
Journal ISSN2352-5568
528views
212downloads

Technical informations

Creation02/03/2019 9:01:00 PM
First validation02/03/2019 9:01:00 PM
Update time03/15/2023 4:23:14 PM
Status update03/15/2023 4:23:13 PM
Last indexation10/31/2024 1:18:21 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack